Cancer marker tests allow the detection of certain proteins that are produced more intensively in the case of certain malignancy, and in some benign diseases or benign tumours. Small amounts of cancer markers that do not exceed established limits can also be found in the body of a healthy person.

In some cancer cases the tumour does not produce any cancer markers, thus blood tests will not show any deviations.
It is important to understand that a cancer marker test alone is insufficient to make a cancer diagnosis; other examinations are also required.

The cancer marker test is recommended:

  • together with other examinations to confirm or rule out cancer diagnosis;
  • in case of predisposition to malignant diseases,
  • to assess the efficacy of anti-cancer treatment,
  • to monitor recurrence of cancer.

The early prostate cancer diagnostics programme, which is implemented in Lithuania and in our Centre is based on a cancer marker test. The blood PSA test, which is a prostate cancer marker, is recommended every second year for all males aged 50 to 75 years and for those above 45 years old if their father or brothers were diagnosed with prostate cancer. If increased PSA levels are reported, other necessary examinations will be performed to confirm or rule out cancer diagnosis.
Many oncological diseases if diagnosed in the early stages can be successfully cured.

Advanced registration is not required for these tests.

Cancer marker tests price

Service
Regular price Regular For clients who are not covered by compulsory health insurance
Prostate cancer antigen 3 in urine (PCA3)

Contact Us

Alpha-fetoprotein (AFP), (mary liver cancer, ovarian germinal cell, testicular germinal cell CA)

Contact Us

Bence-Jones protein in serum

Contact Us

Bence-Jones protein in urine

Contact Us

Beta2-microglobulin (Hodgkin's lymphoma ,non-Hodgkin's lymphoma, plazmacitoma)

Contact Us

Calcitonin*

Contact Us

Carcinoembryonic antigen (CEA)

Contact Us

Chromogranin A (marker of neuroendocrine tumors)

Contact Us

CYFRA 21-1 Cytokeratin 19 Fragment

Contact Us

Free prostate specific antigen (FPSA)

Contact Us

Human appendix testis secreted protein - HE4 (ovarian cancer marker)

Contact Us

Human chorionic gonadotropin (beta HCG), (ovary germinal cell CA, Mola hydatiforma and choriocarcinoma, testis germinal cell CA)

Contact Us

Human chorionic gonadotropin (pregnancy test)

Contact Us

Human epidermal growth factor receptor / neuroblastoma - Her-2/neu (breast cancer marker)

Contact Us

Neurospecific enolase

Contact Us

Paraproteins' identification by immunofixation*

Contact Us

Pro-gastrin relizinis propeptide ProGRP (lung cancer marker)

Contact Us

Prokollagen-I, N-teminal propeptid (P1NP, early prostate and breast cancer metastases in bone sign)**

Contact Us

Prostate specific antigen (PSA)

Contact Us

Ratio of FPSA and total PSA

Contact Us

Resistant acid phosphatase Tatrat-TRAP (bone cancer)

Contact Us

S100 determination (metastatic melanoma sign)

Contact Us

Squamous cell carcinoma antigen

Contact Us

Timidin kinase - TK

Contact Us

Tissue polypeptide antigen TPA

Contact Us

Tissue specific polypeptide antigen TPS

Contact Us

Tumor marker (CA 125), (ovary epithelial cells CA)

Contact Us

Tumor marker (CA 15-3), (breast CA)

Contact Us

Tumor marker (CA 19-9) (CA of large and small intestines, pancreas, liver, ovary epithelial cells CA)

Contact Us

Tumor marker (CA 72-4), (CA of stomach)

Contact Us

Tumor marker Tumor M2-PK in faeces (colorectal cancer)

Contact Us

What factors affect the price?

The prices indicated below apply to citizens of the Republic of Lithuania and the European Union.
If you are coming from another country please check the price by telephoning or sending an email.

More about prices

When are the examinations are carried out:

The time of specific tests and associated data are presented here.
The time of pathology and citology examinations here.

More about the time required for the tests

Checklist for patients prior to blood tests
deco round
Why it is worth

to be examined at our Centre?

  • All our testing is of the highest quality. This is proved by the ISO 15189 accreditation of the laboratory. 
  • The test results will be explained to you by laboratory professionals. This service is offered by only a few laboratories in the country.
  • If necessary, we can carry out additional tests using the same blood sample within 7 days of collecting the original sample. This is important for children or for patients coming from other cities!
  • There is no risk of damaging or mixing up samples during transportation, which is statistically one of the most common causes of sample damage in laboratories. 

Good to know

Are you aware that...

Ovarian cancer is one of the most insidious female diseases, because the first symptoms of the disease are inconspicuous and usually unrecognised. The signs of ovarian cancer are: abdominal pain, increased abdominal circumference, abdominal bloating and a rapidly occurring sensation of fullness in the stomach. Ovarian cancer is usually diagnosed in the late (3-4) stages of the disease and is the fifth highest cause of death among all cancer-related deaths in Lithuania. Females aged above 50 year reaching menopause and post menopause have a higher risk of ovarian cancer. This cancer usually starts silently, thus, cancer marker tests can help to diagnose the disease earlier, when disease symptoms are absent.

The risk of ovarian cancer can be assessed precisely by combining the results of the CA125 and HE4 cancer marker tests. A combination of CA125 and HE4 tests is used to assess the risk of epithelial ovarian cancer by ROMA index (“Risk of Ovarian Malignancy Algorithm“) calculation. Values of the HE4 and CA125 cancer markers and the patient's menopause status should be considered during the assessment of the ROMA index.

How to prepare for the tests?

No preparation is required for the test. Nevertheless Ca125 and HE4 cancer marker tests should not carried out in females just before or during their period.

How to get the test results

The test results will be available after 2-3 hours on working days.

You can pick them up at reception or we will send them to you by email, if you wish.

For interpretation of the test results please contact the laboratory by telephone: (8 5) 247 64 22.

FAQ (frequently asked questions)

Several cancer markers are characteristic of certain malignant diseases (such as – the CA15-3 and CEA markers for breast cancer), therefore all markers characteristic of the specific cancer should be tested before the treatment. The elevated indicator of one of them will be used to monitor the course of the treatment as the main cancer marker.

Cancer marker levels increase when cancer cells are multiplying intensively or in the case of benign processes, however some malignant diseases to not produce markers and they do not appear in the blood, therefore if you experience any symptoms other examinations should be also carried out concomitantly.

Ovarian cancer is one of the most insidious female diseases, because the first symptoms of the disease are inconspicuous and usually unrecognised. The signs of ovarian cancer are: abdominal pain, increased abdominal circumference, abdominal bloating and a rapidly occurring sensation of fullness in the stomach. Ovarian cancer is usually diagnosed in the late ( 3-4) stages of the disease and is the fifth highest cause of death among all cancer-related deaths in Lithuania. Females aged above 50 year reaching menopause and post menopause have a higher risk of ovarian cancer. This cancer usually starts silently, thus, cancer marker tests can help to diagnose the disease earlier, when disease symptoms are absent.

The risk of ovarian cancer can be assessed precisely by combining the results of the CA125 and HE4 cancer marker tests. A combination of CA125 and HE4 tests is used to assess the risk of epithelial ovarian cancer by ROMA index (“Risk of Ovarian Malignancy Algorithm“) calculation. Values of the HE4 and CA125 cancer markers and the patient's menopause status should be considered during the assessment of the ROMA index.

Please do not postpone important decisions - take care of yourself now!

Book an appointment